CETP GENETIC MARKERS FOR STATIN-SPECIFIC CHANGES IN HDL CHOLESTEROL

Details for Australian Patent Application No. 2003228761 (hide)

Owner GENAISSANCE PHARMACEUTICALS, INC.

Inventors REED, Carol, R.; BRAIN, Carlos, D.; DAIN, Bradley, J.; JUDSON, Richard, S.; MESSER, Chad

Pub. Number AU-A-2003228761

PCT Number PCT/US03/13346

PCT Pub. Number WO2003/091698

Priority 60/375,791 26.04.02 US

Filing date 28 April 2003

Wipo publication date 10 November 2003

Event Publications

14 August 2003 Complete Application Filed

  Priority application(s): 60/375,791 26.04.02 US

18 December 2003 Application Open to Public Inspection

  Published as AU-A-2003228761

13 January 2005 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003228762-PREVENTING SECONDARY LYMPHEDEMA WITH VEGF-D DNA

2003228760-METHOD AND SYSTEM FOR RETAINING HIGH VISCOSITY OF FLUID FOOD PRODUCT WITH THE REDUCTION OF GUMS